Abstract
Pulmonary drug delivery has undergone transformative innovations in recent years, driven by the need for effective, targeted, and patient-friendly treatments for respiratory and systemic diseases. Traditional inhalation methods have evolved into advanced delivery systems incorporating nanotechnology, smart inhalers, and personalized therapy models. These innovations aim to improve bioavailability, reduce systemic side effects, and enhance adherence. This article explores key developments including particle engineering, smart delivery devices, and targeted nanocarriers. Emphasis is placed on the integration of digital technologies and emerging trends in inhalation therapies for diseases such as asthma, COPD, tuberculosis, and pulmonary fibrosis. The review highlights current challenges and future prospects in ushering in a new era of respiratory therapeutics.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2021 Dr. Sana Ahmed (Author)